Visionstate Announces $750,000 financing to Support International Expansion and Strategic Growth
Local AI Registry Launches First Public Registry of AI Business Recommendations
Agereh Technologies to Attend 2026 ACI-NA Annual Conference & Exhibition in Philadelphia
FlameProxies Launches Residential Proxy Network Across 180 Countries Without Contract Commitments
cloro Crosses 250 Paying Customers as SEO Platforms Adopt Its API for AI Search Data
New Request for Ideas, the largest in the Foundation’s history, aims to support innovative ideas…
OmniLife’s integrated communication and clinical workflow management platform has been helping Transplant Centers streamline organ…
Global research publisher and information analytics provider optimises contract lifecycle and reduces contract generation time…
The Liquidware and IGEL sponsored study shows how the rapid migration to work-from-home during COVID-19…
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
Company poised for continued growth in a $6+ billion market¹ RALEIGH, N.C., March 24, 2022…
-Primary endpoint analysis expected early Q2 2022- -Final data expected Q2 2022- SAN DIEGO, March…
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company…
CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical…
JERSEY CITY, N.J., March 24, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology…
Founder and CEO, Hing C. Wong, Ph.D., to be guest at “Fireside Chat” MIRAMAR, Fla.,…
Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe Camsirubicin Phase…
NEW ORLEANS and LONDON, March 24, 2022 (GLOBE NEWSWIRE) — Revolo Biotherapeutics (“Revolo Bio” or…
SOUTH SAN FRANCISCO, Calif., March 24, 2022 (GLOBE NEWSWIRE) — VistaGen Therapeutics, Inc. (Nasdaq: VTGN)…
New interim data from TACTI-002 (Part B) evaluating the combination of efti and pembrolizumab in…
Longeveron management presents live at the Second Euro-Geroscience Conference and at a pre-meeting task force…
SUNNYVALE, Calif., March 24, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular…
Trudhesa™ Exceeds Fourth Quarter 2021 Prescription Guidance; Strong Launch Continues Into 2022 Demonstrated by 157%…
Building Momentum with Completion of Patient Enrollment in 4 Late-Stage Trials Multiple Late-Stage Clinical Trial…
On Track to Initiate Phase 1 Clinical Trials in Healthy Volunteers for SZN-1326 and SZN-043…